MONICA THOMAS: Open Payments
NPI 1013245281 · NOTTINGHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 43 payments from 13 companies in 2025. Trend: 2023 $1,658 · 2024 $1,480 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $177 |
| Collegium Pharmaceutical, Inc. | 5 | $110 |
| Averitas Pharma Inc. | 4 | $108 |
| VERTEX PHARMACEUTICALS INCORPORATED | 6 | $106 |
| Globus Medical, Inc. | 4 | $104 |
| Medtronic, Inc. | 1 | $79 |
| ABBVIE INC. | 4 | $79 |
| Saluda Medical Americas, Inc. | 1 | $47 |
| Valinor Pharma, LLC | 2 | $34 |
| Fidia Pharma USA Inc. | 1 | $23 |
Products named: RELISTOR, Belbuca, QUTENZA, JOURNAVX, Senza, SYNCHROMEDII, Evoke, UBRELVY.
Industry payments across MD — which companies pay providers there.
